Opthea

$9.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.23%) Today
+$0.01 (+0.10%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Opthea and other stocks, options, and ETFs commission-free!

About OPT

Opthea Limited American Depositary Shares, also called Opthea, is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.

CEO
Megan Baldwin
Employees
—
Headquarters
South Yarra, Victoria (VIC)
Founded
1984
Market Cap
426.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.60K
High Today
$10.01
Low Today
$9.66
Open Price
$10.01
Volume
973.00
52 Week High
$13.85
52 Week Low
$8.55

You May Also Like

LAZR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure